Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    "Hepatitis D"
Show Display Options
Rank Status Study
1 Completed
Has Results
Pegylated Interferon to Treat Chronic Hepatitis D
Condition: Hepatitis D
Intervention: Drug: Peginterferon Alpha-2a
2 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
3 Completed
Has Results
Lonafarnib for Chronic Hepatitis D
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Other: Placebo
4 Completed
Has Results
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Intervention: Drug: Pegylated Interferon (PEG-IFN) alfa-2a
5 Completed
Has Results
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
6 Active, not recruiting An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis D, Chronic
Intervention:
7 Recruiting Mother-to-child Hepatitis D Transmission
Conditions: Hepatitis D;   Transmission
Intervention:
8 Terminated Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Condition: Hepatitis D
Intervention: Drug: EBP921
9 Recruiting The Hepatitis Delta International Network
Condition: Hepatitis D
Intervention:
10 Active, not recruiting A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
Condition: Hepatitis D, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: placebo;   Drug: tenofovir
11 Active, not recruiting HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
Condition: Hepatitis D
Interventions: Drug: PEG-IFN alfa-2a, Tenofovir;   Drug: PEG-IFN alfa-2a, placebo
12 Recruiting A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
Condition: Hepatitis D, Chronic
Intervention: Drug: Lambda
13 Active, not recruiting Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With Chronic Hepatitis Delta
Condition: Chronic Hepatitis D Infection
Interventions: Drug: Myrcludex B;   Drug: pegINF
14 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine
15 Recruiting Lonafarnib With Ritonavir in HDV (LOWR-2)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: Ritonavir;   Drug: PEG IFN-a
16 Completed Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: PEG IFN-a;   Drug: Ritonavir
17 Completed
Has Results
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
Conditions: Hepatitis D, Chronic;   Hepatitis B, Chronic
Intervention: Biological: Peginterferon alfa-2b (PegIntron, SCH 54031)
18 Recruiting A Long Term Follow-up Study of Patients From the REP 301 Protocol
Conditions: Hepatitis B, Chronic;   Hepatitis D, Chronic
Intervention:
19 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
20 Completed Titrating-Dose of Lonafarnib in Combination With Ritonavir
Condition: Chronic Delta Hepatitis
Interventions: Drug: lonafarnib;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years